Key Highlights聽
-
Robust pharmaceutical demand sustained glutamic acid consumption for antibiotic and anti-inflammatory drug production聽
-
Food sector reformulation trends favored glutamic acid over synthetic substitutes, boosting structural demand聽
-
Exporters accelerated glutamic acid shipments ahead of August xx tariff reinstatement, tightening global availability聽
-
Inland logistics disruptions and warehousing cost inflation in China pressured supply chains and elevated prices
Glutamic acid purchasing in August xxxx was unexpectedly strong in the food and drug-making sectors. Irrespective of the manufacturing indexes reading less than xx, which is a sign of contraction across manufacturing, glutamic acid buying remained active. Pharmaceutical manufacturers experienced constant demand for glutamic acid, which plays an important role in drug production and dietary supplements. Reformulation trends in the food industry favored glutamic acid over synthetic alternatives, particularly in MSG production across Asia-Pacific and North America. There were front-loaded imports prior to tariff reinstatement, generating a one-off peak demand. Forward buying trend was...
